Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0530
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Ayala Pharmaceuticals Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $2.61 million as of August 22, 2025. Its market cap has decreased by -83.23% in one year.
Market Cap
2.61M
Enterprise Value
6.05M
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has decreased from 9.68M to 2.61M, a decrease of -73.00%. That is a compound annual growth rate of -51.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 2.61M | 96.30% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |